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Male rats were exposed to inethylchlorofonn (1,1,J-trichloroethane ) vapors (co ncentration about 2500 PPM) for 24 honrs and t},e
effects of this treatment on drug responses and hepatic drug
metabolism studied 24 hours later to dete:nnine the effect of incthyl ··
chloroforrn on inducible hepatic cl rug-metaboli zj ng c-nzy;nc s .
Exposure to methylchloroforrn vapor significantly

decrc:~sc>d

lhe sleeping time of the rat in response to h exobarbilal (120 mti/kg,
i. p.) and zoxazolamine (80 mg/kg , i. p. ).
Rat blood and liver n1ethylchloroforn1 content mca2ure:d
immediately following exposure suggested that the efi"ects of mclhyl chloroforin were caused by a systemic actio11 .
Expc rirncnts v.-ith 9000 x G supernatants indicated tl"'at the
m .etabolisn1 of hexolnrbital was significantl y increased follc,wing
exposure to nielhylchlorofonn .
Significantly increased N-cle1ncthyJ2.tion of
accon1panicd by inc r e<'.sc<l an1ounts of

n1icr•)SO~r.c..~

am ',n o p~·:-ine,

C0-1: indi;1 _;
0

pig;~it"nt

vi~

(cyloch1orne P-450) and rni 1: rosomal NADPJI-cylocliro1ne £ rcduct.ase
were observed in in

vit2·~

cxpcrirncnts using hepatic n1icroson1al

fractions from rats exposed to.1nethylchlorofonn.

The spectral

properti es of tbe CO-binding pigment in ani.rna l s exposed to n1clbylchl o rofo rrn did not diffc r fron1 controls.
Pretreatn1ent with actinon1ycin Dor cyclohe;.::in-1iclc prevented
the decrease in the hexobarbital sleeping tirne in rats exposed l.o
methylchloroform.

Further studies clenrnnslrateC: that

Drctr.:.:atrn~nt

with cycloheximide prevented the increase in inetabolism of an1inopyrine by l'ats exposed lo n1ethylchlorofonn .
·These observations suggest that the increased drug-n1etab0Jizing
activity in the exposed rats is due to an accelerated synthc.=>is of
hepatic clrug-n1elabolizing systern.

The inducing

-:~ffccts

chlorofonn appea r lo be related lo tho se produced by

th~

oI rnct}1yl-

µh e n c·1:..2rbi'.~· 1.
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I.

INTRODUCTION

Huinans may be exposed to srnall concentrations of methyl chloroform (l, 1, 1 -trichloroethane ) vapors for

extend,~d

periods of

time because of its wide use as an brganic solvent and degreaser .
Knowledge of the possible mechanis1ns of toxic activity of m e lhylchloroform wo uld facili late the d eve lopm en t of a rnetl10d of

detccli.n~

early signs of toxicity of this liquid .
An increase in activity which appears to repre sen t ar1 incn:ased
concentration of enzyme protein is r e ferred lo as "elu:yrne inducli(111. 1'
Induction of hepatic drug-n1etabolizing enz.ymes lec.ds to accelcrc.ted
biotransforrnations of drugs in

~ivo

therefore altering the duration

and inte n s ity of drug actions in co.nirna.ls 2.nd rn;-... n (Conney, 1967 ).
Studies by Gillette (1963) and Booth a1id Gillette (1962) have
shown that foreign co1npounds i:i rats may cnhc.nce the activity of
drug-n-1et abo liz.i,ng enzyn1e s by. at le a~t three cli ffe rent mechar.i s1-:-1s :
one evoked by anabolic ste1·oids, a secor!d by polycydic hyciro c.:.arhons ,
and a third by phenobarbital.
ThE:sc three types of inducer:: s ti:nclate varied palh,,·ays of
drug rn e l a bolism by liver rn:croson1.:::s .
to

detern-1inr~

This rc·scarc h was co1vk<..lc>cl

if rr1clhylchlorof0rrn is an inducer of hepatic drug-_

2

of the above three types of inducers if the above hypothesis proved
correct.
The follo wing para1netcrs of hepatic clrug metabolism were
investigated:
sleeping time;

in yivo studies of hcxobarbital and zoxazolamine
in vitro rnetabolic studies of zoxazol2.minc hyd:roxylase ,

hexob arbita l oxidase, aminopyrine dcmethylase, NADPH cytochrorne c
reductase, and CO-binding pigment; and studies of liver weigh t an d
micro so1nal protein.

Inhi bi to rs of protein syn the sis (actinom.ycin D

and cycloheximide) were used as t ools to block the effect of methylchloro.form on hepatic drug metabolis1n and thereby establish that an
induction process does occur in response to methylchlorofo nn
exposure .

II .

LITERATURE SURVEY

Methylchloroform is a chlorinated hydrocarbon .

It is a highl y

volatile , colorlc s s liquid with a chloroform type odor (Bro wning , 196 5) .
Met abo lism
Methylchloroform is readily absorbed through the lungs
(William s, 1959) .

Stud ies by Hake~ al. (1960) sho\ved that methyl-

chloroform was very stable in the body , and while a large part of an
intravenous dose was excreted unchanged by the lungs , a very small
part was metabolized to chloroethanol and excreted in the u1·ine as the
glucuronatc .
Effects in Anirn.als
The prirnary toxic effect of methylchloro fo nn is central n··-: rvous
systcn1 dcpre s sion producing c:>.'.'.le sthesia.

Lethal dosage ca'.lSe s central

nc rvous s ysten1 depres sio~1 re slllting in l·e spi rato ry paralysis (Adarr1s
et~· ,

1959) .

At the ar..esth·::'!tic level mcthylchlorofcrm sensitizes

the h eart 1..o epin e phrine causing 2.n idiovenlri.cular rhyth1n (Rennick
et al., 19 ·±9 ).

\Vith chroni.c:: expo su re (500 PPM, 7 h ours a day, 5

days a \vcek for 6 months) no e:vidence of in1painn cnt of growth or
h ealt h v.. as obs erved

ii~

rats, rabbits, guinea pigs, and rnonkeys .

In

another study at 2000 PPM for 3 nlcmt hs, the only anin1al s pecies in

4

which organic injury was observ'3d was the fema le guinea pig.

These

organi c l esions included slight inflammation of the lu ngs and fatty
changes in t}ie liv e r (Torkelson et al., 19 58 ).

The l ethal dose in rats

by i nhalation is 30, 000 PPM fo r 6 minutes ; 15, 000 PPM for 1 -1/ 2
hours; and 8000 PPM for 7 hours

(Adams~

al., 1950).

Effects in Man
St ewart et al. (1 961 ) have reported data obtain e d when seve n
hum an subj ects we re exposed to constantly increasing concentration s
of methylchloroform up to 2650 PPM over a period of 15 minutes .
At 1000 - 1100 PPM and 1 900 -2000 PPM mild eye irritation and throat
irri tation was noted, re spe ctively, in 6 of the 7 subj ects .

At 2650 PPM

2 subjects were unable to stand and 3 subjects \Vere very lighth eaded but able to stand .
lighth cadedn~

In another test at 9 10 PPM for 35 rniDutcs ,

s s was exp.c ri enced in one of two subjects .

subj e ctiv e and phy sio l ogica l responses agreed with the
by Torkelson

~t

Th ese

r e sul~s

r epcirtcd

a l. (1 958 ).

S tcvvart et al. (1 96 1)

also rn easured the blood ar:d unne of

subj ects exposed to methylchloroforrn..

Depending on length of

exposure an'l concentration of methylchloroforn1, blood s2.rnples ccin tained up to 10 PPM and urine sarnp l es up to 2 PPM at the tcr1nin ;:;tio n
of exposure .

Thirty minutes after ·2xposure only t race arooun ts

( (1. 0 PPM) of ID·'.:! thylchloroforrn could be found in lh '2! blood or
urin e .

5

Previous investigations (Lal and Shah, 19 68 ) have suggested
a possible role of mcthylchloroform as an inducer of hepatic drugmetabolizing enzymes in rodents .

O xidative

Dru_g_~etab~.!_is~

Early investigations have established that the enz.ymati c.
metabolism of foreign compounds is carried out by enzymes located
in the inicrosomal fraction of the liver and are dependent on the
generation of NADPH by the soluble fraction.

Although the mechanism

of drug oxidation by inicroso1nes is not yet cJear, M as on (1957) proposed that the oxidative reaction is coupled to a microsom.a l electron
transport system. ope rating between NADPH and oxygen.

Siekevitz

(1965) has r evi ewe d the n1icrosomal electron transport systems an d
suggests that the -following pathway may be operative for the passage
of electrons from NADPH to oxygen:

NADPH

Fiavoprotei n

~,

? ----, cytochro1ne

P-450

~\.

I

''

Exogenous
c ytoch ro1nc C

drug

·o xidized drug

Cytochrorrc P-450 is the microson-1al hernoprotcin that is believed to
function as the oxygen-activating en z.yrne and te rnii nal oxidase for
hydroxylaling a nu1nbcr of drugs and steroids .
existence of this cytochrome

'.V<tS

Evid ence for the

first presented by Kli.ng cnbc rg (1958)
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and Garfinke l (1 948 ) and has since been extensively studied by Omura and
Sato (1964).

The he1noprotein can be characterizc<l by its reactivity

with carbon inonoxide and ethyl. i socyanide .

The pigment has been

termed cytochrome P-450 because in the reduced form reaction with
carbon monoxide exhibits an absorption inaximum at 450 mp .
In 1965 Cooper et al.

presented evidence for the participation

of cytochrome P-450 in NADPH dependent rnic rosomal systems
respon sib le for the inetabolism of many drugs .

They showed that the

liver micro sornal oxidation of codeine, 4-rnononi.ethylarninoantipyrine, and acetanilide was inhibited by carbon rnonoxide and that
this inhibition could be reversed by monochromatic light at 450 rnµ or
by oxygen .

Kuntzman ~ al. (19 6 8 ) irnplicated cytocb rome P-4 50 as

the terminal oxidase for steroid hydroxylation of te sto ste rone by liver
enzymes with his findings that the hydroxylation of te stos teron e by

li vc r mic rosoni.e s could be in hi.bi ted by carbon monoxide and that
this inhibition was reversed by rnonochromatic light.
At the pre sent ti1ne the re is a question as to whether li vc r
rnicrosoni.cs contain 0ne or rnore different heinoprote ins that function
in hyd roxyla.tion reactions.

Remme r and Merker (196 5) and Sladek

and Manncring (1966) have sho,vn that ph enobarbi tal or 3-methylcholanthrenc increases th e conc e ntration of cytochro1ne P-450 .
Alvares

~~~ l.

(1967) and Kuntzrnan et al.

(1968) have shown that

in

3-mclhylcholanthrcne treated rats, carb0n rnonoxide interacts with the

7

reduced microso1nal hemoprotein to give an absorption maxirnuin at
448

mp

instea d of an absorption maximum at 450 mp which i.s seen

in the untreated and phenobarbital treated rats.

Imai and Sato (1966)

also presented evidence for two forrns of cytochrome P-450 based
on different spectral properti es seen with phenobarbital or
3-m e thylcholanthr e ne tr eate d rats when ethyl isocyanide was used as
the ligand for the reduc ed h ernopro t ei n.

It is feasible that

3-methyl-

cholanthrene or its metabolite binds to the hemoproiein, and this
bound h emoprote in pos sesses sp e ctral properties different from
untreated or phenob ar bital tr eated rats.

Other possibili.ties are the

induc e d synthes is of a spectrally different hemoprot ein or in conversion
of one form of he mo prote in to anolhe r fo rn1 in the presence of the
inducer.

Kuntzman et al.

(1 968 ) and Alvares et al.

(19 6 7) have shown

that pretr eahnent of rats with e thionine or -actinomycin D prev ente d
the peak s hift to 448 1np caused by 3 -methylchol anthrene .

In vivo

administrati on of 3 -methylch.alanthr ene to" anirnals 2 hours prior to
sacrifjc e or in

'.':'.:_i tr~

addition of 3-m et hylcholanlhr ene to microsomal

susp ension did not cause any spectral changes (Ku ntzman~ c.l., 196 8).
These r esults sugges t the s yn thes is of a new h en10protein but the t 1·ue
solution will have to \Va.it for solubili za lion and purification of the
hen1opro tein(s ) found

ir1

norrnal, phenobarbital and 3-mcthylcholanlhrE.;ne

anirnals.
Jick and Shu ster (J.966 ), Ern s ter and Orr cni us (1 965 ) and RcmnlCr
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and Merker (1965 ) have reported that treatment with phenobarbital
increases liver microsomal NADPH cytochrome.£ reductase levels
in the rat al1nost two fold .

Von Der Decker and Hultin (1960) and

Kato and Takayanaghi (1966) demonstrated that the administration of
3-methylcholanthrene had no effect on NADPH cytochrome.£ reductase .
Thus , NADPH-cytochrome .£ reductase and P-450 are established as
compon e nts of the o xida tive drug -n1eta bolizing syste1n of liver
micros01nes and the activity of same should be evaluated in the presence
of suspected induction of the drug-mctabolj zing enzymes .

At the present time at least 200 chemicals have been identifjecl
as induce rs of drug-m etabolizin g enzymes (Conney, 1967) .

In studic s

where two different types of inducers (i . e., phenobaTbital and
3 -methylcholanthrene) we re used together, liver microson1e s we re
more active than studies where each was used alone or where two
drugs of a similar type (i . e ., 3-methylcholanthrene and 3, 4benzpyr ene } were u sed tog ethe r (Gillette, 1963) .

A similar in vitro

study using ACTH and 3, 4-bcnzpyrene (with zoxazolan1ine as the
substrate) and phenobarbital and in ethy l testosterone (with nl.onomethyl-tJ -anljno antipyrine as the substrate.:) showed a sti1nulalion
of drug rn etabolism. more t han n1axin1u1n doses of 3, 4-benzpyrene or
phen obarbita l could proch:ce.

This indicated a third possjb1e

inducer, the an abo lic steroids.

ty~ c

of

9

These three general types of inducers stimulate varied pathways
of metabolism by liver mic rosomes.

The re is a large overlap in the

types of reactions and in specific pathways induce<l with individual
drugs or chemicals.

In general, 3-methylcholanthrene sti1nulates a

more limited group of reactions than phenobarbital or the anaboli c
steroids .
Conney et al. (1960) and Kato and Takayanaghi (1966) have
shown that 3-m ethylcholanthrene increases the metabolism of
zoxazolamine in rats but has no effect on the in vitro rnetabolism of
hexob arbital or aminopyrine, while ph en obarbital significantly incrc;;ased
the

metabolisn~

metabolisn~

of all three drugs.

Anabolic steroids increase the

of h exobarbital (Booth and Gillette, 1962); stimulate the

N-dc methylation of aminopyrine (Kato and Takay anag hi, 1966); but do
not significantly alter zoxa zolarnine hydroxylase activity (Gillette,

196 3; Kato and Takayanaghi, 1966).
Hexo barbital slec ping time is often used as an accurate indicator
of inicrosom.al drug metabolism .

The duration of hexobarbital hypnosis

in rats is si.gnificai1tly shortened by treatment with ph eno barbital
(C onney~_!. al.,

19 6 0) :rnd anabolic steroids (Booth and Gillette, 1962)

but is not alter c:d by 3 --rnctl:yi cho lanlhrene type drugs (Conn f:'y

1960 ).

!'._~

?-l·,

The duration of :z.oxazolarninr? paralysis is s ignificantly l"E: duc:r::d

by trcalrnent of cats \\'itl1

ph ~' 11obarbilal

or 3-methylcholanthrcne

(Conney~~·, 1960), or in mice by a : -iabolic steroid s (Novick~~:, 196 0) .

10

The time required for the various types of induce rs to produce
an effect differs .

While phenobarbital produces stimulatory effects

on enzyme activity in 1-4 days (Conney et al.,

1960), polycyclic

hydrocarbons take only 3 lo 6 hours with maximum effects observed
in 24 hours (Conney et al., 1956).

Methyl testosterone induction is

not apparent except after prolonged administration {weeks) (Booth and
Gilette, 1962).
Phenobarbital, polycyclic hydrocarbons, and anabolic steroids
may increase the l evels of liver microsomal enzyrnes by stabilizing
these enzymes as well as by accelerating the rate of Eynthesis.
Kinetic s tu dies with mouse tis sue have shown that phenobarbital
causes an increase in liver NADPH-cytochrome !'.:. reductase levels by
increasing the rate of synthesis and by decreasing the rate of breakdown
(Rubin~~- ·, 1964).

While phenobarbital causes a 20 -40% increase in rni c ro son1al
pro"tcin per gra:::n of liver
(Con ney~

(Conney~

al., 1960), 3-methylcholc:,nthrcne

al. , 1960) and the anabolic sle raids (Booth and Gill e tte,

1962 ) cau se no incr ease in microsoinal protein per gram of liv e r.
Pheno barbital and 3 -rnethylcholanthrene ad ministered to rats for
2 to 3 days increased tl1e liver to body weight ratios 20 to 30% but
prolonger! treatment v.rith anabolic s t eroids did Pot signi f ica ntly
cha.nge this ratio.
Electron microscopic exa1nination of si·nooth surfaced

l l

endoplasrnic reticulum is a useful index of drug induced changes
in li vc r n1.ic rosomal enzyn1e levels.

Phcnobarbi tal causes pro life ra -

tion of smooth surfaced endoplasn1.ic reticulun1. in liver cells but has
little effect on rough surfaced endoplasmic reticulum, while
3 -methylcholanthrene has little or no effect on smooth surface d
endoplasmic reticulum (Rc!nmer and Merker, 1965).

Inhibitors of Protein

Synthi::_::_~~

The induction of drug-metabolizing enzyme activity by phc no barbital or 3 -methylcholanthrene is blocked by ethionine

(Conney~ ~l_.

,

195 6; Conney ~al. , 1960); puromycin (G e l boin and Blai:::kburn, 1964;
Orr enius et al. , 1965); ar.d actinomycin D (Gelboin and Blackburn, 1964;
Orr enius ~ al. , 1965).
These inhibitors blo_ck protejn synthesis by various mechanisn1s.
Ethionine appears to block protein synthesis by decreasing the ATP
levels in the liver (Villa-Trevino~ al., 1963); purornycin has been
reported to block the transfer of soluble RNA-bound amino acid into
microsomal protein (Yarrnolinsky and De La Haba, 1956); and actino mycin D binds to DNA, and therefore may act by blocking the DNA
directed synthesis of nuclear RNA required for protein synthesis
(.R eich et~., 1961) .

Ho weve r, R eic h (1 964 ) has also reported that

actinornyc i n D inhibits strand separation of h e lical DNA and suppresses
DNA polymerase activity.

Thus it is clear th at actinornycin D
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activity is exerted at the level of the nucleus.
Cyclohexim.ide, another known inhibitor of protein synthesis,
is reported to act on extranuclcar co1nponcnts .

Korner (1966) reported

that the liver ribosomes of :rats given cycloheximide by intraperitoneal injection incorporate less amino acids into protein than
ri boson1e s from control rat liver.

Their experiments showed that

.
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cycloheximide treated animals incorporated 95% less 1-leucrne C
into ribosomal proteins.

Studies by Harris et al.

(1968) show that

a single dose of cycloheximide in rats inhibited the incorporation of
3
uridine- H into nucleolar RNA with maximum inhibition at 24 hours.

III.

EXPERIMENTAL

Animals
Male Sprague -Dawley d er ived rats obtained from Charles
River Breeding Laboratories (Wilmington, Mass .) , weighing
between 60 2.nd 100 gin . we re used throughout the course of this
study .

The animals were maintained on commercial laboratory chow

and water ad libitum.

Rats were used not earlier than four days

after being received from the supplier via commercial shippers
or were used the following day when personally picked up at the
source of supply.

Rats we re n1aintaine d in a room with controlled

tempc rature and alternating 12 hour periods of li ght and darkness .
All drugs were adrninistered via the intraperitoneal route .
Mate rials
Analytical reaGent grade chemicals O·r equivalent were used
throughout this study.

Co -factors (NADP, NADPH, glucose -6 -

phosphate, cytochrome£• and glucosc-6-phosphate dehydrogeP.ase)
and cry stal.line bovine scrum albun1in were purchased from
Calbi oche1n.

The drugs used in this investigation were obtained

£ro1n their respective m.anufacturers.

The toluene used was the 25%

fraction th a t re1nained after distillation.
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Inhalation Chamber
The chamb e r consisted of a flat bottom cylindrical glass jar
(12 11 x 18 11 ) placed horizontally on a wooden pl atform .

The open end

of the jar was closed by a wooden frame with a cork ring .

The

wooden frame was fitted with a removable circular wooden hatch
(9/2" diameter) for the introduction of animals and a 4-hole rubber
stopper (2 1 1 diameter) .

Two copper tubes reaching the end of the jar,

a copper tube r ea ching only the front of the jar, and a th e rmometer
were inserted through these holes .
Methylchloroform Exposure Protocol
The animals we re plac ed into the inhalation cham.ber onto a
perforated platform .

The exposure atmosphere was

forn~ed

by the

passing of air at a rate of 0 . 2 liters/minute through a gas drying
bottle containing methylchloroform and subsequent dilution with air
at a flow rate of 10 liters air/n1inute .

Equilib riun1 of the chamber

atmosphere was achieved by introducing the air mixture through the
long copper tubes described above with venting via the short copper
tube.

The desired flow rates were n1aintained by the use of flow meters

(Ho ke, Inc., Style 993) .

The animals were a.llo we d fr ee access to food

and water for the entire p eriod of exposure .

At the end of the exposure,

they were transferred to battery cages until used.

The exposure pro-

tocol used for all studies relating to drug n1etab0Esm was a single
24 hour exposure with observations n1ade 24 hours after the terinination
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o f exposure .

Those animals used for U1e

a~; sc..y

of liver and b l ood

were sacrificed irnrnediate l y upon removal fl'om the cham.bcr .

An Aerograph Autoprep A-700 Gas Chromatograph (Vari.ens,

I nc . , California ) equipped \\rith a t hermal conduci-ivit )' detector with
a Speeclornax X recorder ··.vas usc:d to lne:asu.rc the: conccntral.ion o f
methylchloroform in the exposure chambc:r .

k1 18% Hi Eff-3J3P on

60/80 Chro1nosorb w A- 1 0 colmnn (m.:ope1,tyl succ-i.n ::~tc on acid
\vashcd chrornosorb) obtained from. Applied Sdcnce: (Pbilacklp!1ia., r.:.<:1. )
was used .

The column tcrnperature was set to about 73°C, injector

t en1perature t o auout 1 30

0

c,

and detector temperature t:-i abo it 83
1

The filament was set at 200 ina .
was used as the- carrier gas .

at ;:in

sar;1 p1':~,

ci.Uerw:~ tio11

c.

Helium. with a gas flow of 60 in} /n1innte

For the standard, 2 pl of pure rnethyl-

chlorc•fon n was injcc1f-: d i;1to the inslrun1cnt at an attenurtti.u:"!
For the

0

':'•f

J 6.

. 20 lnl of cha1nber air was injected into thr:: ch<,1;1bcr

of 2.

The areas i..rn c1er the standard an<l s<. .rnple peak:1

were calculated and i-'pn:.. \•;ere clcterrn inecl using the equivalent
1 mg/liter= 1S3 pprn (Bro w 1,:ng, Vi 6 5) .

extracteci \\'ith 2 volun-1es of toluc·n C'.

J\.n A t.: rograph Hy Fi Moc'.cl
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Electron Capture Detector with a tritium source and a Honeywell
Electronic 118 Recorder was used.

A 20% GP 29A, ABS 60 /70 column

(20% carbowax 20M terminated with terephthalic acid groups on acid,
alcohol, base washed diatomaceous earth) obtained fro1n Anal abs , Inc.
(Hamden, Conn.) was used.
at a flow that permitted

Nitrogen was used as the carrier gas

maxin~um

separation.

Since the determination

was not linear, the following n1ethylchloroform concentrations \.Ve re
used as standards:

0. 1, 0. 5, 1. 0, 2. 0, 4. 0, 5. 0, 6. 0, 8. 0, 10. 0 ppn1

and a standard curve drawn.

Two pl of all samples and standards

were injected into the instrument.

Peak heights were measured and

the sample concentrations determined by extrapolation frorn a standard
curve.
Determination of Sleeping Time
Duration of pharmacologic response of the depressant drugs
employed in this study was measured using sleeping ti1ne as an endpoint.

Animals were weighed,_ marked, and placed into cages i1n-·

mediately ?rior to use.

Hexo barbital solutions we re prepared in

distilled water with a s1nall amount of lN NaOH in a concentration
which permitted the adn1inistration of 10 ml/kg.

Zoxazol2.n~ine

was

prepar e d as a suspension in 0. 5% methylcellulose in a conc entrat ion
which also permitted the administration of 10 ml/kg.

Sl ee ping time

was take n as the length of time b etween the loss and regaining of the
righting reflex.
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Collection of Biological Samples
Blood.

Methylchloroform-:reated animals were sacrificed

immediately upon removal from the exposure chamber (exposed

24 hrs . at atmospheric concentration of about 2500 ppm mcthylchloroform) by decapitation and the free-flowing blood collected in
a beaker containing a few drops of 33% sodium citrate solution.
blood was frozen until assayed .

The

Blood from control rats was collected

in the same manner .
Liver .

Immediately after decapitation and collection of blood

(above), the livers were removed, homogenized in 1 volume of 0. 1 M
phosphate buffer (pH- 7 . 4) and extracted with 2 volumes of toluene .
These samples were stored in the freezer until assayed for methylchlorofo rm.

Control experiments established that no

me~hylchlo!"ofo

nn

was lost during storage.
Preparati o n of Liver Microsomes
Animals were sacrificed by cervical

~islocation,

the abdomen

opened and the livers p e rfused with 1.15% KCl solution via the hepatic
portal vein .

The livers were quickly excised, weighed, minced with

scissors, a.nd homogenized for 60 seconds in 2 volmnes of ice cold

0.1 M phosph ate buffer (pH 7. 4) in a motor driven coaxi a l homogenizer.
The homog enates were centrifuged for 30 1ninutcs al 0° and 10, 000 rpn1

(9000 x Gave . ) in an Int ernationa l model B-60 preparative ultracentrifuge (r o tor #874).

The supernate was decanted and centrifuged at

18
30, 000 rpm (78, 000 x G ave.) for one hour to obtain the microsomal
fraction.

The m .icrosomal pellet was washed and resusp ended in

cold 0. 1 M phosphate buffer (pH 7. 4) in a volume equivalent to that
of the original liver.

Aliquots of the microsomal suspension and

78, 000 x G supernatants we re frozen and stored at -10° C until
assayed.
Preparation of 9000 x G Supernatants
Rats were sacrificed by cervical dislocation, and the livers
homog enized as described above .
was taken after centrifugation at

The 9000 x G supernate fraction

o0 c

at 10, 000 rpm in an Inter -

national #874 rotor for 30 minutes and stored at -10°C until assayed.
Determination of Protein

9000 x G supernatant and microsomal protei n were estimated
by the method described by Lowry~ al., (1951).
liver equivalent for

About 165 mg· of

the 9000 x G supernatants and about 333 rng

of

liver equivalent for microsomes were plac ed into 50 ml c ent rifuge
tubes containing enough 0. 5 N NaOH for a final volume of 10. 0 ml.
The tubes were placed i nto a wa ter bath and heated at 75°C until
dissoluti on was complete.

Standard solutions of fr eshly prepared

cryst alline bovine serum albmnin in 0. 5 N NaOH and a blank consisting
of 0. 5 N NaOH soluti c, n were carried through the entire procedure .
When the ti ssue was complet e ly di sso l ved , an 0. 2 rn.l (9 000 x G supernatants) or 0. 4 ml (n1icros ornes ) aliquot \\·as \vithdrawn and placed into
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a second tube containing 1. 0 ml o f 0. 5 N NaOH .
(1. 0 ml of 2. 7% potassium tartra te ~

~

Five ml of reagent A

Hz O, 1. 0 ml of 1. 0% CuS 0 4 · 5Hz0,

and 100 ml of 2 . 0% NazC 0 3 ) was added and the tubes mixed and allowe d
to stand at room temperature for 20 minutes .

Then 0. 5 nu of reagent

B (cornmercial folin phenol reagent diluted to 1 N with distilled water )
was added and the tubes mixed and allowed to stand at roorn tempera ture for 40 m.inutes b e fore being read in a Beckinan DB-G grating
spectrophotometer at 50 0 mµ versus an 0. 5 N NaOH blank.
Determination of

!E. ~~

N -demethylation of Aminopyrine

The method of McMahon and Easton (1962) was em ployed to
measure the formaldehyde form.ed during the in vitro N-demethylation
of aminopyrine by liver fractions .

A typical incubation mix tu re con -

tained 1. 0 ml of 9000 x G supernatant or 1. 0 ml of 78, 000.x G super natant and 1. 0 ml of microsomes (about 333 mg of live r equivalent),
10 pMoles of aminopyrine (substrate), 45 µMoles of semicarbazide ,
30 µMoles of glucose --6-phosphate, 4 µMoles. of NADP, 50 pMole s of
MgClz · 6Hz 0, 50 pMoles oi nicotinamide, and 300 pMoles of 0 . 1 M
phosph ate buffer (pH 7 . 4) in a total volume of 5 . 0 ml in 25 ml
myer flasks .

erlen-

Parall e l incubation flasks containing 1. 32 µMoles of

forinal dehyde (sl2.nclard) in pl::ice of substrate and distilled \vater
(blank) in plac e of sub st rate were carried through the entire procedure .
Tbc fla sLs \\·ere incubated in a Dubnoff shaker at 3 7° C uncle r air
for 30 minutes .

At the end of the in cu b ation p eriod , the flask conte nts
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were poured into centrifuge h1bes .

Four ml of 10% zinc chloride

(prepared with COz-free water) were added and the tubes mixed .

Two

ml of a saturated solution of barium hydroxide were added and the
sarn.ples again mixed .

The tubes were centrifuged for about 10 minutes

and 5. 0 ml aliquots of the clear supernate s we re transferred to clean
centrifuge tubes containing 2. 0 ml of double strength Nash reagent
(0. 04 M acetylacetone in 0 . 4 M ammonium acetate -0.1 M acetic acid).
the contents we re mixed and the tubes heated in a water bath at 60°C
for 30 n1inutes .

The colors were read against the blank using a

Beckman DB-G grc..ting spectrophotometer at 410 mµ.
Determination of In Vitro Metabolism of Hexobarbital
The method described by Cooper and Brodie (1953) was used
to measure the disappearance of hexobarbital from. incubation medi.a.
The basic incubation mixture and cop.ditions as previously described
were used with sernicarbazide o;-i1itted and hexobarbital
substrate .

1

as the

After incubation for 30 rninutcs at 37°C in a Dubnoff

shaker, t11e iL:.._sk \·olmne s \.ve re transfer red to 50 ml centrifuge

2
tubes containing l. 0 gm. NaCl and 1. 5 ml phosphate buffer (pH-5. 5) .

1 A standard solution \Vas prepared by dis solving 91. 5 rng of hexo barbital in 200 ml of ciistilled water with 1. 2 ml of 1 N N aOH. Incubation mi::-: ture ust!d 1. 0 rnl (1. 9 4 µMoles He x obarbital Na) of the stand a rd
soluti o n in total volun1 e of 4. 0 n11.

2

Prepar c d by adding 8. 5 ml oi 0. 119 Gm Na 2 HP0 4 1!1 10. 0 ml to 191. 5 ml
of 1. 82.0 Gn1 I~HzP04 in 200 rnl 2.nd washed with petrol e un1 ether containing L 5% isoan1yl aJ c o hol.
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Thirty ml of washed p e troleum ether

1

containing 1. 5% isoamyl alcohol

was added and the mixtures were shaken for 45 minutes and centrifuged for 10 minutes.

Twenty ml aliquots of the solvent phase were

transferred to clean tubes and shaken w ith 10. 0 ml of phosphate

2
buffer (pH-11)

for 10 minutes.

petroleum ether was removed .

The tubes were centrifuged and the
The optical densities of the unmetabo-

lized h exobarbital (aqueous phase) were d e t ermined at 245 mp. on a
Beckn1an DB -G grating spectrophotometer .

Two parallel incubation

fl2.sks were carried through the proc edu re , one containing 100 µgm
hexobarbital sodium (standard) with boiled tissue and the other containing tissue but no hexobarbital sodium to serve as the blank.
Determination of In_ Yit.r.o Metabolis1n of Zoxa zolamine
The i._1'} vitro hydroxylation of zoxazolamine was n1ea su red by
the method of Juchau et al. , (1965) . The basic incubation mixture and
conditions as previously described were used with semicarbazi<le
3

omitted and zoxazola1nine
1

2

3

as the substrate .

Aft e r incubation, 2. 0 rnl

Solv ents were purified oy washing with 1 N NaOH, 1 N HCl and two
washings ·with distilled •..vatc r . A technical grade of petroleum ether
was adequate but a reagent grade of isoa1nyl alcohol was needed.
Pr e par ed by adding 8 . 5 Grn of NaOH to 500 . 0 rnl of 0. 8 M Na2HP0 4
anhy drou s .
A standard solution 'Nas prepared by dissolving 50. 0 mg of zoxazolarnine in 50 ml of 0.1 M phosphate bu ffe r (pH 7. J- ) with a small arnom1t
of 0.1 N I-TCl. Incubation mixtu;e used 0. 5 ml (3. 0 µMoles zoxazolatni nc) of tl:c st<;, ncla rd solul i.on in a total volun1c of 5 . 0 nil.
1
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of the incubate was shaken with 25. 0 rn.l of h eptane containing 1. 5%
isoamyl alcohol and 0. 5 ml of 1. 0 N NaOH for 30 minutes and
centrifuged for 5 minutes .

Twen ty ml of the heptane layer was

pipetted into a second centrifuge h1be containing 7. 0 ml acetate
buffer {pH 5. 6), shaken for 5 minutes, and centrifuged for 5 minute s.
Fifteen ml of the h e ptane layer was shaken for 15 minutes with 7 . 0 ml
of 0.1 N HCl and centrifuged for 15 minutes .

The optical density of

the aqueous phase was read at 278 mp against a 0.1 N HCl blank on
a Beckma.r, DB-G grating spectrophotometer .

The arnount of

zo xazolan:1ine metabolized was calculated as the difference in the
amounts extracted from zero time (unincubated) and the incubated
flasks.
Dete nnination of Microsomal NADPH-Cytochron1e

~

Reductase

Activity
The system ernployed for the estimation of NADPH-cytochrorn.e c
reduct ase was a n1odification of that described by Ernster e t al., (196?..)
and Dallner (1963) .

This assay is based on the detern1ination of the

rate of reduction o f cytochrome£ through measure1nent of thE:
absorbanc:e increase of the reduced cytochrome at 550 mµ .
Microson1al suspension containing 0. 5 mg /ml of protein 1n
0.05 M phosp:!--iate buffer (pH 7.4) were employed for this assay .

The

assay syster:n contained 0. 67 ;u.Molc:s NADPH, 0. 33 µMoles cytochrome£• and 0. 99 pMoks KCN in 0. 05 M phosphate buffer (pH 7. 4 )
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rn a total volume of 3. 0 ml.

These r eagents we re pl ace d in both the

reference and sample cuvettes of a Beckman DB -G grating spectrophotometer equipped with a th ermostatic cell compartment held at
37°C a n d a B e c kman lin ea r-log pot entiornetric recorder (Model 1005).
A 0 .1 ml aliquot (0. 0 5 mg of protein) of microsomal suspension was
introduced into the sample cuvette and mixed.

The linear change

in absorbance over a 5 minute p eriod at 550 mp was recorded.

An

extinction coefficient of 18. 5 x 10 3 at 550 mp for reduced minus
oxidized cytochrome£ (Margoliash, 1954) wa s used in the calculations.
The results were expressed as pMolcs of cytochrome£ reduced per
minutes per mg n1icrosomal protein .
Determin ation of CO-Binding_!2gment (P-450)
The system employed for the estimation of CO-binding pigm ent
(cytochro~e P -45 0) was _ similar to that described by Dalln e r (1963).

The assay was conducted in a Cary Model 15 recording spe ct rop hotometer.
To 6 . 0 ml microsomal suspension (pr epared in 0. 0 5 M
phosphate buffer (pH 7. 4 ) to contain 1 mg protein/m l) a few mg of
Na dithionc..te were added to reduce the rnicrosomal pigments.
ml of n1icros o rnal

Three

suspension were placed into each of 2 cuvett.es and

the spectrum recorcled from 500 to 400 n:1p .

Carbon ino noxide was

bubbl ed through the sa.mple cuvette for a period of 1 minute .

The

speclrun1 was again scann e d fr o rn. 500 to 400 m.µ and lhe absorbance
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recorded.

The absorbancc at 500 mp and at 450 mµ was taken from

the recording and the content of the CO-binding pigment was expresse d
as the difference in absorbance between 450 and 500 mp. per rng of
micro so1nal protein.

Statistical Methods
test (Dixon and Massey, 1957) was used to test

Student's t

for differences between means throughout this investigation.

The

formula en1ployed is as follo'ws:
t

= xl

-

2
Sp

Xz
(nl

+ n2)

nl nz

2
where;

s

p

2

=

-1) s

l

(n

2

2

-1) s

2

-2

X1

=

control mean,

n

=

c ontrol sample size,

1

2

s1

X2

= treatment
n2

mean

= treatlnent
size

2

=- control variance, s 2

=

treatnwnt variance

Calculationf; we re p ~ rfo rrnt:!d on an IBl'A. 360 cornpute r.
was written in Fortran four language.
taken as n 1

+n2

group sarnple

-2.

The program

The de gre8 s of freeclom. we re

The l eve ls of p \ ;:ere taken from appendix 5

(Di xon and Massey, 195 "/).

IV.

RESULTS

In all expe rirnents rats were exposed to a mcthylchloroform
atmosphere (about 2500 ppm) for 24 hours .
Methylchloroform Concentration in the Exposure Chamber.
The concentration of methylchloroform versus the two flow meters
was deternlined several times throughout the investigation.

The flow

rates used for all experiments (0. 2 liters/minute diluted with

10 liters air/minute) corresponded to a chamber atmosphere content
of about 2500 ppm .
Methylchloroform Content of Rat Blood and Liver Following
24 Hour Exposure .

Methylchloroforn1 was found to be highly con-

centr ated in the liver (12 7 ppm) in contrast to the blood (12. 5 ppm) of
rats exposed to the methylchloroforrn vapor (about 2500 pprn) for 24
hours (Table 1).

Control experiments established that no methyl-

chloroforrn was lo st from blood s an1ple s collected and stored in a
fre ezer before extraction with toluene .

A pe_ak corresponding to

me thylchlorofonn was observed in control samples although these
anin-ials had no known exposure to n1ethylchloroforn1 .

This peak

corresponds to instrurnent sensitivity .
All of the f ollowing data were obtai11ed 24 hours a f te r tern1ino.tion
of a 24 hour period of exposure to the methylchloroforin atrnospl:erc .
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TABLE 1
ANALYSIS OF METHYLCHLOROFORM IN THE BLOOD AND LIVER
OF MALE RATS

Liver
Controls
Treated

2

Blood
Controls
Treated

1

2

pg/gml

mµMolcs/gm

(3)

<.

<.. 0.

(3)

127.3~8.7 3

954.3

pg/ml

mpMoles/gm

(7)

<.

< o.

(8)

12.5 - 2.3

0. 1

0. 1

+

7

~ 65. 1

7

93. 7 ~ · 17. 2

Ug/gm were determined by gas chromatography using an A ero graph Hi. Fi Chromatograph Model 600- D..
Treated ani1nals exposed to atmospheric concentrations of about
2500 ppm methylchloroform for 24 hours.

3 Results are expressed as mean values + standard error .
Number of sa!nples is in parentheses.
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Effect of Methylchloroform on Hcxobarbital Sleeping Time and Hexobarbital Oxiclase
Hexobarbital sleeping time was significantly (p (0. 001) decreased
(70%) in rats exposed to methylchloroform vapors (Table 2A).

In

other experiments, decreases ranging from 45-80% were observed.
Significant (p (0. 001) increases of 30% in hexobarbital oxidase were
observed in hepatic 9000 x G supernate of rats exposed to methylchloroform (Table 2B).

These results are in agreement with experi-

ments performed in mice (Lal and Shah, 1968).
Effect of Mcthylchloroform on Zoxazolami.ne Sleeping Time and
Zoxazolami.ne Hydroxylase Activity
Zoxazolamine sleeping time was significantly (p ( 0 . 01) decreased
by 55 - 60% in rats exposed to methylchloroform (Table 3A) .

This

was accon1panied by a 20% increase (p~O. OS) in in vitro- microsomal

- -- -

zoxazolamine hydroxylase activity (Table 3B).
Effects of Methylchlo roforrn on Several Hepa.tic Microsomal Para -

The liver/body weight ratio was significantly (p<:O . 05) increased
by 29% .

The trend in the experime nts was for an increase of 20 - 30%

in the ratio, but an incr ea se was d e rnon s trated in oaly half the experiments.

As far as microso1nal prote in per weight of iiver, this

ratio never increased.
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TABLE 2A
EFFECT OF METHYLCHLOROFORM ON HEXOBARBIT AL SLEEPING
TIME IN .THE MALE RAT

Sl eeping time~
(min. ± S. E.)

90. 8 +
- 4. 9

Controls
Methylchlorofo rm

3

1

Sleeping time taken as duration of loss of the righting reflex.
{Hexobarbital Na 120 mg /kg).
2 Results are expressed as the mean values obtained from 11
animals ± standard error.
3
Methylchlo'roform animals exposed to atmospheric concentrations of about 2500 ppm methylchloroform for 24 hours.
~' P<0.001.

TABLE 2B
EFFECT OF METHYLCHLOROFORM ON THE METABOLISM OF HEXOBARBITAL IN RAT LIVER 9000 X G SUPERNATANTS

- - - - - - - - - - - - - - - - - -- - - - - - - -----·---pMoles]gm

2. 541

Co'n trols
Melhylchloroform

1

2

+ o.

3. 365 -±:

o.

liver/30 min.

'!:

S. E.

1

061

096'~

Results are expressed as the mean values obtained frorn 10
ani1nals -± standard error .
2 l'v1ethylchloroforn1 anirr.2.ls cxpc.secl to atmospheric concentrations
of about ?.500 ppm rncthylcblorofonn for 24 hours.
·'-~· P <o. ooi.
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TABLE 3A
EFFECT OF METHYLCHLOROFORM EXPOSURE ON ZOXAZOLAMINE
SLEEPING TIME IN THE MALE RAT
.
.
1
Sl ecp1ng time
2
(min. -!: S. E. )
Control

#1

12 4 -!: 20. 5 (7)

56 -!: 6. 8>!' (6)

Expt #2

106 t 17.5 (7)

42

Expt

!

5. 5':' (7)

1

Sle e ping time taken as duration of loss of righting reflex.
(Zoxazolamine 80 mg /kg).
2
Results are expressed as the mean values -± standard error with
size in parentheses .
3 MC :-: methylchloroform ani1nals exposed to abnospheric concentrations of about 2500 pp1n methylchloroform for 24 hours.
~- P <0.01

J.

TABLE

3B

EFFECT OF METHYLCHLOROFORM ON ZOXAZOLAMlNE HYDROXYLASE ACTIVITY IN THE MALE RAT

mµMoles/mg micros o mal prote in ./ 30 min.
i S. E. 1

Expt

#1

Expt # 2

Control

MC 2

210 . 9-± 13. 2

256.1!1 4 .4 ...

177. 8

-t

2. 7

2 16 . 6

!

1 2 . s o::

1Results are e xpressed cir; fh e me a n values ob tai n e d fro1n 5 c:i.n im als
±standard error.
2 MC :: n1 ethylchlorofo rrn ri.ni n-1als e x p o s e d to a lm.o s ph e ric conc e ntrations of about 2500 p pm me lh y lchlor ofo r m for 24 hours.
'~p ~o . o5 .
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Further examination of Table 4 indicated the typical significant
(p (0. 001) increases in CO-binding pigmen t (P-450) and NADPHcytochrome £ reductase activity by 40 and 34%, respectively.
Spectral peaks of P-450 for both control and rnethylchloroform
treated samples were the same, at. about 451 mp.
A 62% significant (p (0. 001) increase in demethylation of
aminopyrine in the same group of rats. was also noted.
experiments 40 - 80% increases (p

<.O.

In other

001) rn the metabolism of

aminopyrine were obs e rved.
Effects of Cyclo11e x imide on Various Paramete rs 0£ Hepatic Drug
Metabolism in the Male Rat
Cycloh eximide , an extra-nuclear protein inhibitor, was used to
prevent the decrease in hexobarbital sleeping time and increase in
in vitro metabolism. of

aminopyr~ne.

The data in Table 5 indicat e

that the significant decreases in hexobarbi.tal sleeping tirne and significant increases in d e 1nethylation of aminopyrine caused by methylchloroform treatmc!1.t, can be block ed by pretreatment with cyclo heximide .
Data for liver we ight and supernatant protein are also pr esente d
in Table 5.

The methylchloroforn1 plus cycloheximide group was not

different fron1. the methylchlo:rofonn plu s saline group as far as
weight of liver per -...vcight of rat ratios but was significantly decreased
(P (0. 001) in supernatant protein per gram of liver.

TABLE 4
EFFECTS OF METHYLCB 1_,0ROFORM O N SEVERAL HEPATI C MICROSOMAL CON STITUENT S IN
THE MALE RAT
Wt. Liver per
Microsomal
Br,ciy '0/t. ra~io
protein per
1 wt. liver ratio
(r!:.g /gm ± S . E. )
(mg/gm '. . S. E.)
.J_

Control

53.4 +
- 3.9

15.2±

3

68 . .;I. +
3. 3

15.4"± 1.0

;vrc

"p" value

.(. 0.05

7 0. 5

1.2

CO-binding
Hgment (P - 450)
(A450 - 500 /mg/ ml
protein ± S. E.)

NADPrt - cyto chrome c re ductase (pM/mg
protein/min "!:
S. E.)

0 . 053±0 . 003

0. 333

± 0.

± 0. 003

0 . 44 7

~

0 . 074

<: 0 . 001

018

0 . 0 12

< 0.001

Demethylase
(aminopyrine)
2
(m,uMoles HCHO
mg protein) t
S.E.

176 . 6±5 .5
286. 5

± 1 7. s

<0.0 01

1

Results are expressed as n1ean values from 6 anirnals ± standard error.
2 HCEO :: forrr.alflehyde .
3 MC = Methylchloroform animals exposed to atn1ospheric concentrations of about
2500 ppm methylchloroform for 24 hours .

w
.....

TABLE

5

EFFECTS OF CYCLOHEXIN'llDE ON VARIOUS PARAMETERS IN THE MALE RAT
Para1ncte r

liver wt/wt
of rat i a1..io
{mg/gm live r
t S . E.) l

Hexobarbi tal
9000 x G
2
supe rnatar.t
Sleeping Time
protein (mg/gm (min t S. E.)
.
+
liver - S. E . )

Aminopynne
Metabolism
(rnµMo~es

HCHO /mg
protein I
30 min . ±
S.E . )
Gro~

Co!ltrol & saline
MC

4

52.9±0 . 8

& saEne

Contra~

& cyclo

MC & cyclo

4i.s±o .7

5

95 . 6 ± 2.4
104.4

.l..

!.

3.5

78. 3 ± 7. 7
14 . 9

.l..
.!..

0. 9

36 . 8 t 2. 2
64. 6

± 7. 0

47 . 7±1.8

88 . 5 +
- 2. 1

121.5±4.1

23_5±2 . 2

50.o±i.1

84 . 8 ± 2. 5

87 . 1±9_7

24.8 t2 . 6

Results are expressed as mean vali.les of six rats ~ standard error.
2 Sleeping time Laken as duratio::i. of loss oi righting r~flex. (Hexobarbital Na 120mg/kg.)
3 :I CI-IO = form.al dchyd.c.
4 ?viC = mefoylc hlo rofo rm animals exposed to atmuspl:e ri c con.cent rations of about
2.500 ppm rncthylchlor0£orm for 24 hours .
5 Cyclo =- cydohcximide (2. 5 mg/kg) half hour be±:o!"e MC treatment.
1

w
N

...
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Effect of Aclinomycin Don H cxobar bital Slcepin_g_

Tim~-~~

the

Ma~R~

Treatlnent with actinomycin D (protein ir,hibitor at the nuclear
level ) at a dose of 40 µg/kg 30 min . b efore n1et.hylchloroform treatment
and 40 µg/kg 12 hours l ate r did

I !O t

prevent th e signific;"\.nt clecrt:ase in

hexobarbital sleeping tin1e caused by meLhylchloroform (Ta~Jle 6A}.
A dose of actinomycin D 80 µ g/kg 30 min. before methylchloroforrn lr ealrnent and 40 p g/kg 12 r.o ,ns later caused a. sjg11i ficant
inhibition (pt:.. 0 . 01) of the methylchJorofo.rm induced
h exobarbiial sleeping time (T able 613) .

d~ crcase

in
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TABLE

6A

EFFECT OF ACTINOMYCIN DON IIEXOBARBITAL SLEEPING
TIME IN THE MALE RAT
______ T ___________ _
Sleeping lime
2
(rnin.-!: S.E.)
Gr~~

112.5 -!: 8.7

Control
4
MC
C ontro 1

. 5
&. acbno

MC & actino

44. 8 t 6. 0
111. 5

+ 12. 2

51.7-±:

(6) 3
(6 )
(6)

8.3(6)

1

Sleep)ng tirnc taken as duration of loss of righUng reflex .
2 ResultG are expressed as the mean values-!: st<Jnclard error .
3 Animals pc r group.
4
MC = n1ethylchlorofo rn-1 ani rnals exposed to atmosphc ric con centrations of about 2500 ppn-i methylchloroform for 24 hours.
5
Actino = actinomycin D 40 µg/kg 30 min. before MC treatm e nt and 40 µg/kg 12 hours later.

TABLE 6B
EFFECT OF ACTIN01\1YCIN D ON HEXOBARBIT AL SLEEPING
TIME IN THE MALE RAT
------ · ---------------Slce~°ing

;irne 1- - - - - - - - - - - - - · - - - - -

(min. -!." S . E.)
gl.:~~.P
con l rol
4
MC

11 6

Con t r ol &. actino 5
MC & aclino

+
+

5. 7

(7)3

2. 1

(8)

118 + 4 .2

(8)

48

72 t 7. 1

2

(10)

Sleeping 1.irrie taken as c~uration oi loss cf ri.ghtin ~ n:flcx- .
2 Results are cxprc"!ssed ac, th-=. ni.can V2.1u es t stancl<inl C'rror.
3
P.nirnals per group.
4
MC:.. n1cthylchloro.:-orrn an}1nals e:-cposecl lo ati~usph~r!c ct~J~ 
ccntrabons of about 2500 ppm 1ncthylchloroic.rin for 2-1 h .. :.:r~~ .
5 Actino = act.inon1ycin D 80 uglkg 30 mi ·1. before MC treatment and 40 ,u g /kg 12 hours lalc r.

V.

DISCUSSION

This investigation indica.ted that hepatic drug-metabolizing
enzyrnes in rats are stimulated by exposure to methylchlo:::oform
vapor.

Methylchlorofonn was detected and measured in the liver and

blood of exposed rats thus providing justification for a hypothesis
that methylchlo roform exerts a systemic effect.

Studies by Stewart

et al. (1961) in humans confirmed that methylchloroform blood concentrations are related to exposure .
Exposure to m ethyl chloroform vapor significantly shortened
he xobarbital and zoxazolamine sleeping time as do inducers of the
phenob ar bital type (Conney~ al., 1960) and anabolic steroid type
(Booth and Gillette, 1962; Novick~ al., 1966).

Induc er s of the

3-methylch0lanthr e ne type only reduce zoxazolamine sleeping tin1e
(Conn e y~ a~.

, 1960 ).

In vitro paramete rs of drug metabolism (hexoba rbit.al oxidase ,
aminopyrinc N-d en1ethy l ase , and zoxazol an1ine hydro xylase) 'vvcre
significantly increased by n1et.hylchJ orofo nn exposure.

Phe no b ar bital

has been reported to cause increases in the sarne p ara1n eter s (Conney

et al., 1960; Kato and Takayanaghi, 1966).
significantly increase thel2!

~iJ:I.<.?

Anabolic stc roids

metabolism of hexobarbita] and

arninopyrine (Bouth and Gillette, 196?.; Kato and Tak2yanaghi, 196 6 ).
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but do not significantly altc>r the hydroxylation of zoxaz.olamine (Gillclte,
196 3; Kato and Takayanghi, 1966).

3 ..:Methylcholanthrene increases

the metabolism of zoxazolamine, but not aminopyrine or hexobarbital
(Conney Eal. , 1960 -; Kato and Takayanghi, 1966).
Methylchloroform significantly increased the levels of NADPHcytochrorne £ reductase and the content of CO ·-binding pigment (P-450)
and did not change the spectral properti es of the hem.oprotein (P- 45 0)
when corn.pared to controls.

Treatment of rats with phenobarbital

significantly increases the activity of the liver microsomal NADPHcytochrome £ reductase (Jick and Shuster , 1960; Ernster and Orr eni us,
1965) and the content of CO-binding pigment (Kuntzman~ al., 1968)
without changing the spectral properties of this pigment.

Kato and

Takayanaghi (1966) and Von Der Deeken and Hultin (1960) have
cle1nonstrate<l that lreatment with 3-methylcholanthrene had no
effect on NADPH-cytochrorne £ reductase activily while Alvares et al.
(1967) and KuntzmanE al. (1968) have shown increases in the content
of CO-binding pigrnent, but with different speclral properlies when
comp a red lo controls .
Inhibitor s of protein synthesis have been demonstrated to
block the increase in hepatic drug mctabolisrn by known inducers.
Pretreatment of animals wilh actinomycin D and cyclohcximide
prevented the induction of significant decreases in hexobarbital
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sleeping tirne by methylchloroform.

The increase in the metabolis1n

of aminopyrine was also blocked by cyclohexirnide pretreatment.
These data support the hypothesis that the increase in drugmetabolizing enzymes of anin1als exposed to methylchloroform
rep re sen ts an induction of mo re enzyme protein .

VI.

SUMMARY AND CONCLUSIONS

Rats were exposed for 24 hours to an atmospheric concentration
of about 2500 PPM methylchloroform and in

~~ro

and in vivo parameters

of drug metabolism were measured 24 hours after the termination of
exposure .
( I ) Methylchloroform content was 10 - fold greater in the liver
than the blood of exposed rats sacrificed immediate ly upon re!Tioval
from the chamber.

These findings suggest that methylchloroform acts

systemically .
(2)

Hexobarbital and zoxazolamine sleeping tin1e s we re

significantly decreased by exposure to methylchloroform vapor .
(3)

In vit!::_<2_ metabolism of hexobarbital, zoxazolamine, arnjn o-

pyrine, NADPH-cytochrome £ reductase, and content of CO-binding
pig ment '-''ere significantly increased in animals exposed to methylchlorofonn .
(4)

Actinomycin D and cycloheximide blocked the rnethy l-

chloroforn1 induced clccrC;c..se in hexobarbital sl e eping ti1ne .

Cydo-

he x in1ide block ed the methylchlo rofo rm in due ed inc n:~ase in dernethylrt tion of aminopyrine.

These data suggest that the increase in tbe drug -

metabolizing enzyrncs of the anin1a l s exposed to n1ethylchlorofon11
was mediated through the synthesis of protein .
(5)

The spectrum of eT'. z yn1cs inclucccl by rn e thy!chlorofo-cm
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appears to be closely correlated with the spectrum of enzymes induced
by phenobarbital.
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